Risperdal Consta
Product manufactured by Janssen Pharmaceuticals, Inc.
Indications and Purposes
1 Indications And Usage Risperdal Consta ® Is An Atypical Antipsychotic Indicated: For The Treatment Of Schizophrenia. ( 1.1 ) As Monotherapy Or As Adjunctive Therapy To Lithium Or Valproate For The Maintenance Treatment Of Bipolar I Disorder. ( 1.2 ) 1.1 Schizophrenia Risperdal Consta ® (Risperidone) Is Indicated For The Treatment Of Schizophrenia [See Clinical Studies (14.1) ] . 1.2 Bipolar Disorder Risperdal Consta ® Is Indicated As Monotherapy Or As Adjunctive Therapy To Lithium Or Valproate For The Maintenance Treatment Of Bipolar I Disorder [See Clinical Studies (14.2 , 14.3) ] . |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Risperidone |
|
ZINC538312 |